Cambridge Innovation Capital

Cambridge Innovation Capital is a venture investor backing life sciences and deep technology companies associated with the Cambridge ecosystem. The firm invests across the company lifecycle, from seed and Series A through later growth stages, and pairs capital with technical and commercial guidance, along with connections within and beyond Cambridge. Its stated remit includes supporting founders in commercialising research drawn from the University of Cambridge and the wider regional innovation community.

Sector coverage spans life sciences and deep technology, with named areas of interest including artificial intelligence, quantum computing, genomic diagnostics, surgical robotics and cancer therapeutics. Portfolio patterns reflect this: the firm's stated verticals range from biotechnology and pharmaceutical work on cancer therapies to medical devices and computational fields. The investment offer is structured around two elements - staged capital from seed to growth, and non-financial support in the form of technical and commercial input.

Cambridge Innovation Capital is based in Cambridge, UK, and operates within the University of Cambridge ecosystem. The team describes itself as combining deep scientific knowledge with commercial expertise and operational experience, and frames its purpose as increasing the successful commercialisation of life sciences and deep-tech innovation while generating positive societal impact. A shared interest in science and its capacity to drive change is cited as shaping how the team works with founders.